Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Icebrg	7/23/2005 4:46:34 AM
	of 3044

The cost of COR. From the 8-K filed upon the close of the merger. As a result of the Merger, each outstanding share of COR's common stock was converted into the right to receive 0.9873 of a share (the "Exchange Ratio") of the Company's common stock, par value $.001 per share ("Common Stock"). Excluding shares issuable upon exercise of options assumed by the Company and upon conversion of outstanding COR convertible notes, the Company expects to issue approximately 55,038,103 shares of Common Stock in the Merger. At the end of 2001, just before the merger was closed, the company had around 220 million shares outstanding. So, in a way one may now conclude that "they" gave away 20 % of the company in exchange for the stream of royalties to be earned from SGP, Apart from that, I don't think there is much else left in Millennium, that came out of Cor Therapeutics. (Actually, I thought it was even worse. One can at least argue that Integrilin has and will provide MLNM with a steady stream of income during a critical phase of the company's transition to the real world(?).) Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next